Form 4: Insight Holdings Group Sells $40 Million in Hinge Health Class A Stock Following IPO Conversion

Insight Holdings Group, a significant shareholder and director of Hinge Health, Inc., reported the sale of 1,250,000 Class A Common Stock shares at $32.00 each, totaling $40 million, in connection with the issuer's initial public offering.

Summary

• Insight Holdings Group, LLC, along with its affiliated Insight Venture Partners funds, reported a series of transactions on May 23, 2025, related to Hinge Health, Inc.'s initial public offering (IPO).
• The reporting entities, identified as a 10% owner and director, converted 1,250,000 shares of Class B Common Stock into an equal number of Class A Common Stock shares.
• Immediately following the conversion, 1,250,000 shares of Class A Common Stock were sold at a price of $32.00 per share, resulting in gross proceeds of $40,000,000.
• Prior to these specific transactions, various series of preferred stock (Series B, C, C-1, D) held by Insight entities were converted into Class B Common Stock.
• After the reported transactions, Insight entities collectively retain beneficial ownership of 11,029,604 shares of Class B Common Stock, which are convertible into Class A Common Stock.
• The remaining Class B Common Stock holdings are distributed among IVP X (5,508,113 shares), IVP Cayman X (4,516,719 shares), IVP Delaware X (873,715 shares), and IVP X Co-Investors (131,057 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale occurred, it was part of an IPO, which is generally a positive milestone for a company. The reporting entity retains a substantial stake, indicating continued interest.

Positives

• The successful completion of Hinge Health, Inc.'s initial public offering (IPO) indicates market confidence and provides liquidity for early investors.
• The sale of shares at $32.00 per share demonstrates a specific valuation achieved for a significant block of stock during the IPO process.

Negatives

• A significant sale by a 10% owner and director, even as part of an IPO, could be perceived by some investors as a reduction in long-term commitment, although it is a common practice for venture capital firms to realize gains post-IPO.

Future Outlook

The document does not contain any explicit forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on past insider transactions.

Industry Context

This Form 4 filing reflects a typical event for a company that has recently undergone an Initial Public Offering (IPO) in the digital health sector. Venture capital firms like Insight Holdings Group often monetize a portion of their holdings post-IPO to realize returns for their limited partners, while retaining a significant stake for future upside.

Related Party Transactions

• The reported transactions involve Insight Holdings Group, LLC and its affiliated funds, which are identified as a 10% owner and director of Hinge Health, Inc., making these related party transactions.

Stakeholder Impact

• Shareholders: The sale by a major institutional investor could lead to short-term price volatility but also provides liquidity and confirms a market valuation for the shares.
• Company: The IPO itself, which facilitated this transaction, provides capital and enhances the company's public profile and access to future funding.

Key Dates

Keywords

Hinge Health, HNGE, SEC Form 4, Insider Trading, Beneficial Ownership, IPO, Stock Sale, Insight Holdings Group, Venture Capital, Equity Conversion